microdosing glp-1 for arthritis Why Microdosing? A Closer Look at Reported Benefits GLP-1 Medications and Rheumatoid Arthritis:

Other studies dont use humans, and if they do, the population sizes are on the smaller side

Important Disclaimer: AOD-9604 is sold for research purposes only and is not FDA-approved for human use

Lixisenatide, a structurally modified derivative of exendin-4, addresses some of these limitations by offering a longer half-life of approximately 3 h, thereby permitting once-daily dosing (Leon et al., 2017)

DISCUSSION BPC 157 was suggested to be a link between inflammatory bowel disease and multiple sclerosis, that could be also used in practice per-orally (as an anti-ulcer peptide, stable in human gastric juice) (5-7, 9), and thereby, being equally effective against the models of both of those diseases